Pain management devices market was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, registering a CAGR of 6.7% from 2019 to 2026.
Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are different forms of pain management devices available in the market.
Major Key Players of the Pain Management Devices Market are:
Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp, DJO Global LLC, Johnson & Johnson (Codman And Shurtleff, Inc,), Kimberly Clark Corporation, Medtronic Plc, Pfizer, Inc., Stryker Corp.
No comments:
Post a Comment